## Review setup
- **Input scope** Full manuscript (abstract and main text)
- **Assessment boundary** Scientific content, methodology, claims, and evidence as presented in the provided text
- **Shared manuscript claim summary** The authors propose ID3, a gradient-based optimization framework for mRNA sequence design that treats trained deep learning models as differentiable functions and optimizes continuous probability distributions over codons, enabling simultaneous optimization of RNA accessibility and codon adaptation index (CAI) while preserving the encoded protein sequence.
- **Visible evidence base** Abstract, main text (sections: Motivation, Results, Availability and Implementation)
- **Missing materials affecting confidence** No figures, tables, or supplementary materials were provided. No detailed methods section, experimental validation data, or comparison with existing methods were visible. The convergence analyses mentioned are not accessible.

## Reviewer
- **Overall assessment** The manuscript presents a conceptually interesting approach to a well-recognized problem in mRNA design. The idea of treating trained models as differentiable functions and optimizing input probability distributions is a clever workaround for the discrete nature of codon optimization. However, the provided text is too brief to assess the technical soundness, reproducibility, or practical utility of the method. Critical details about the constraint mechanisms, optimization procedure, and validation are absent.
- **Who would be interested in the results, and why** Researchers in mRNA therapeutics, vaccine design, and synthetic biology would be interested, as codon optimization is a routine but computationally challenging step. The potential to simultaneously optimize multiple objectives (accessibility and CAI) using gradient-based methods could offer efficiency gains over existing discrete optimization approaches.
- **Major strengths** 1. The core idea of optimizing continuous probability distributions over codons while preserving the amino acid sequence is novel and addresses a fundamental limitation of gradient-based methods in discrete sequence design. 2. The framework is model-agnostic, meaning it could be applied to any differentiable predictor, which increases its potential impact. 3. The availability of code and data is commendable for reproducibility.
- **Major Concerns**
    - **Concern ID** R1-M1
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Technical soundness
    - **Claim pointer** "ID3 treats trained models as fixed differentiable functions and optimizes input data through continuous probability distributions while preserving the encoded amino acid sequence through three constraint mechanisms."
    - **Evidence pointer** Not provided in the visible text
    - **Concern** The manuscript does not describe the three constraint mechanisms, how they are implemented, or whether they guarantee exact preservation of the amino acid sequence. Without this information, the core technical contribution cannot be evaluated.
    - **Why it matters** The constraint mechanisms are central to the method's validity. If they are not rigorous, the optimized sequences may not encode the intended protein, rendering the method unusable for real applications.
    - **Resolution test** The authors must provide a detailed description of each constraint mechanism, including mathematical formulation, implementation details, and proof (or empirical demonstration) that they preserve the amino acid sequence exactly.

    - **Concern ID** R1-M2
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Evidence sufficiency
    - **Claim pointer** "The framework shows strong performance in both accessibility optimization and joint accessibility-CAI optimization across diverse protein targets."
    - **Evidence pointer** Not provided in the visible text
    - **Concern** No quantitative results, figures, or tables are presented to support the claim of "strong performance." The text does not specify which protein targets were used, what metrics were measured, or how performance was compared to existing methods.
    - **Why it matters** Without empirical evidence, the claim of strong performance is unsubstantiated. The reader cannot assess whether ID3 is practically useful or merely a theoretical exercise.
    - **Resolution test** The authors must present quantitative results, including at least: (a) performance metrics (e.g., predicted accessibility scores, CAI values) for ID3-optimized sequences, (b) comparison with baseline methods (e.g., random codon selection, existing optimization tools), and (c) results for multiple protein targets to demonstrate generalizability.

    - **Concern ID** R1-M3
    - **Severity** Major
    - **Blocking** Yes
    - **Axis** Reproducibility
    - **Claim pointer** "We also provide convergence analyses from the perspective of trained model input optimization."
    - **Evidence pointer** Not provided in the visible text
    - **Concern** The convergence analyses are mentioned but not described or shown. It is unclear what was analyzed, what conclusions were drawn, or whether the optimization reliably converges to useful solutions.
    - **Why it matters** Convergence analysis is critical for understanding the reliability and practical applicability of any optimization method. Without it, users cannot know whether ID3 will find good solutions or get stuck in poor local optima.
    - **Resolution test** The authors must present the convergence analysis, including at least: (a) the metric used to track convergence, (b) typical convergence behavior across multiple runs and targets, and (c) discussion of any failure modes or sensitivity to initialization.

- **Minor Comments**
    - **Concern ID** R1-m1
    - **Severity** Minor
    - **Axis** Clarity
    - **Affected element** Abstract
    - **Evidence pointer** Location not provided
    - **Issue** The abstract states "optimizes input data through continuous probability distributions" but does not explain how discrete codon choices are ultimately made from these distributions.
    - **Required correction** Clarify whether the final sequence is sampled from the optimized distribution or obtained via a deterministic procedure (e.g., argmax), and discuss any implications for optimality.

    - **Concern ID** R1-m2
    - **Severity** Minor
    - **Axis** Completeness
    - **Affected element** Results section
    - **Evidence pointer** Location not provided
    - **Issue** The text mentions "diverse protein targets" but does not list them or explain why they were chosen.
    - **Required correction** Provide a list of the protein targets used, along with their lengths and any relevant properties (e.g., GC content, secondary structure propensity).

    - **Concern ID** R1-m3
    - **Severity** Minor
    - **Axis** Readability
    - **Affected element** Motivation section
    - **Evidence pointer** Location not provided
    - **Issue** The phrase "navigating a vast discrete combinatorial space" is vague. The size of the space is not quantified.
    - **Required correction** Provide a concrete example or estimate of the search space size (e.g., for a 300-codon protein, there are 61^300 possible sequences).

- **Technical failings that need to be addressed before the case is established** R1-M1 (constraint mechanisms not described), R1-M2 (no quantitative results), R1-M3 (convergence analysis not shown). These three concerns are blocking and must be resolved for the manuscript to be considered scientifically sound.

- **Assessment against Nature-style criteria** 
    - **Originality**: The idea of optimizing continuous probability distributions over codons is novel and addresses a genuine limitation of gradient-based methods. This is a strength.
    - **Scientific importance**: mRNA design is a timely and important problem. If validated, ID3 could be a useful tool. However, the current evidence is insufficient to judge its impact.
    - **Interdisciplinary readership**: The work bridges machine learning and molecular biology, which is of interest to a broad audience. The abstract is accessible to nonspecialists.
    - **Technical soundness**: Cannot be assessed from the provided text. The core technical details (constraint mechanisms, optimization procedure, validation) are missing.
    - **Readability for nonspecialists**: The abstract is clear, but the main text is too brief to be informative. The lack of figures or tables makes it difficult to follow.

- **Recommendation posture** Currently not established from the provided evidence. The manuscript presents a promising idea, but the absence of critical technical details and empirical validation prevents any meaningful assessment of its validity or utility. The authors should be invited to resubmit a complete manuscript with full methods, results, and convergence analysis.

## Risk / unsupported claims
- "ID3 shows strong performance in both accessibility optimization and joint accessibility-CAI optimization across diverse protein targets." — Unsupported; no results provided.
- "The framework shows strong performance" — Unsupported; no quantitative evidence.
- "We also provide convergence analyses" — Unsupported; analyses not shown.
- "ID3 treats trained models as fixed differentiable functions" — The feasibility of this depends on the specific model architecture (e.g., whether it is fully differentiable), which is not discussed.